Mutations in the circadian gene CLOCK in colorectal cancer

Molecular Cancer Research

Volumn 8, Issue 7, 2010, Pages 952-960

  Alhopuro, Pia ^a,b   Björklund, Mikael ^c,d   Sammalkorpi, Heli ^a   Turunen, Mikko ^c,d   Tuupanen, Sari ^a   Biström, Mia ^a   Niittymäki, Iina ^a   Lehtonen, Heli J ^a   Kivioja, Teemu ^a,c,d   Launonen, Virpi ^a   Saharinen, Juha ^a   Nousiainen, Kari ^c   Hautaniemi, Sampsa ^c   Nuorva, Kyösti ^e   Mecklin, Jukka Pekka ^e   Järvinen, Heikki ^b   Orntoft, Torben ^f   Arango, Diego ^g   Lehtonen, Rainer ^a   Karhu, Auli ^a   Taipale, Jussi ^c,d   Aaltonen, Lauri A ^a   more..

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; GLUTATHIONE TRANSFERASE; PROTEIN P21; RAD50 PROTEIN; TRANSCRIPTION FACTOR CLOCK; CLOCK PROTEIN, HUMAN; MICROSATELLITE DNA;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL STRAIN HEK293; COLORECTAL CANCER; DNA CONTENT; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IONIZING RADIATION; MICROARRAY ANALYSIS; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC MUTATION; WILD TYPE; ADENOCARCINOMA; AMINO ACID SEQUENCE; COLORECTAL TUMOR; FRAMESHIFT MUTATION; GENETICS; HCT116 CELL LINE; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; TUMOR CELL LINE;

ADENOCARCINOMA; AMINO ACID SEQUENCE; BASE SEQUENCE; CELL LINE, TUMOR; CLOCK PROTEINS; COLORECTAL NEOPLASMS; FRAMESHIFT MUTATION; GENE EXPRESSION PROFILING; HCT116 CELLS; HUMANS; MICROSATELLITE REPEATS; MOLECULAR SEQUENCE DATA; MUTATION;

EID: 77955438266     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-10-0086     Document Type: Article

References (30)

1. Hunt T, Sassone-Corsi P. Riding tandem: circadian clocks and the cell cycle. Cell 2007;129:461-4.
2. Fu L, Lee CC. The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer 2003;3:350-61.
3. Bertolucci C, Cavallari N, Colognesi I, et al. Evidence for an overlapping role of CLOCK and NPAS2 transcription factors in liver circadian oscillators. Mol Cell Biol 2008;28:3070-5.
4. Lowrey PL, Takahashi JS. Genetics of the mammalian circadian system: photic entrainment, circadian pacemaker mechanisms, and posttranslational regulation. Annu Rev Genet 2000; 34:533-62.
5. Liu C, Li Y, Semenov M, et al. Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002;108:837-47.
6. Gery S, Komatsu N, Baldjyan L, Yu A, Koo D, Koeffler HP. The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell 2006;22: 375-82.
7. Mullenders J, Fabius AW, Madiredjo M, Bernards R, Beijersbergen RL. A large scale shRNA barcode screen identifies the circadian clock component ARNTL as putative regulator of the p53 tumor suppressor pathway. PLoS One 2009;4:e4798.
8. Zheng B, Albrecht U, Kaasik K, et al. Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell 2001;105:683-94.
9. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002;111:41-50.
10. Bae K, Jin X, Maywood ES, Hastings MH, Reppert SM, Weaver DR. Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock. Neuron 2001;30:525-36.
11. Wood PA, Yang X, Taber A, et al. Period 2 mutation accelerates Apc-Min/+ tumorigenesis. Mol Cancer Res 2008;6:1786-93.
12. Haus E. Circadian disruption in shiftwork is probably carcinogenic to humans. Chronobiol Int 2007;24:1255-6.
13. Aaltonen LA, Salovaara R, Kristo P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998;338:1481-7.
14. Loeb LA. A mutator phenotype in cancer. Cancer Res 2001;61:3230-9.
15. Kruhoffer M, Jensen JL, Laiho P, et al. Gene expression signatures for colorectal cancer microsatellite status and HNPCC. Br J Cancer 2005;92:2240-8.
16. Alhopuro P, Phichith D, Tuupanen S, et al. Unregulated smooth-muscle myosin in human intestinal neoplasia. Proc Natl Acad Sci U S A 2008;105:5513-8.
17. Salovaara R, Loukola A, Kristo P, et al. Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol 2000;18:2193-200.
18. Woerner SM, Benner A, Sutter C, et al. Pathogenesis of DNA repair-deficient cancers: a statistical meta-analysis of putative real common target genes. Oncogene 2003;22:2226-35.
19. Bjorklund M, Taipale M, Varjosalo M, Saharinen J, Lahdenpera J, Taipale J. Identification of pathways regulating cell size and cell-cycle progression by RNAi. Nature 2006;439:1009-13.
20. Zelzer E, Wappner P, Shilo BZ. The PAS domain confers target gene specificity of Drosophila bHLH/PAS proteins. Genes Dev 1997;11: 2079-89.
21. Pongratz I, Antonsson C, Whitelaw ML, Poellinger L. Role of the PAS domain in regulation of dimerization and DNA binding specificity of the dioxin receptor. Mol Cell Biol 1998;18:4079-88.
22. Kumaki Y, Ukai-Tadenuma M, Uno KD, et al. Analysis and synthesis of high-amplitude cis-elements in the mammalian circadian clock. Proc Natl Acad Sci U S A 2008;105:14946-51.
23. Yan J, Wang H, Liu Y, Shao C. Analysis of gene regulatory networks in the mammalian circadian rhythm. PLoS Comput Biol 2008;4:e1000193.
24. Giannini G, Ristori E, Cerignoli F, et al. Human MRE11 is inactivated in mismatch repair-deficient cancers. EMBO Rep 2002;3:248-54.
25. Zhong H, Bryson A, Eckersdorff M, Ferguson DO. Rad50 depletion impacts upon ATR-dependent DNA damage responses. Hum Mol Genet 2005;14:2685-93.
26. Gekakis N, Staknis D, Nguyen HB, et al. Role of the CLOCK protein in the mammalian circadian mechanism. Science 1998;280:1564-9.
27. Antoch MP, Gorbacheva VY, Vykhovanets O, et al. Disruption of the circadian clock due to the Clock mutation has discrete effects on aging and carcinogenesis. Cell Cycle 2008;7:1197-204.
28. King DP, Zhao Y, Sangoram AM, et al. Positional cloning of the mouse circadian clock gene. Cell 1997;89:641-53.
29. Debruyne JP, Noton E, Lambert CM, Maywood ES, Weaver DR, Reppert SM. A clock shock: mouse CLOCK is not required for circadian oscillator function. Neuron 2006;50:465-77.
30. Kinzler KW, Vogelstein B. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 1997;386:761-3.